Nebraska Tech Daily
SEE OTHER BRANDS

Top science and technology news from Nebraska

Nebraska Tech Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nebraska Tech Daily.

Press releases published on May 13, 2025

Oragenics, Inc. Announces Approval to Initiate Phase II Concussion Drug Trial in Australia

Oragenics, Inc. Announces Approval to Initiate Phase II Concussion Drug Trial in Australia

SARASOTA, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company focused on developing novel intranasal therapies for brain-related disorders, today announced that it has received approval from the Human …

Wearable Devices Receives U.S. Patent Notice of Allowance for Hybrid Voice and Gesture Control Innovation

Wearable Devices Receives U.S. Patent Notice of Allowance for Hybrid Voice and Gesture Control Innovation

Newly allowed patent extends Wearable Devices’ innovative gesture technology into the domain of voice control YOKNEAM ILLIT, ISRAEL, May 13, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), a …

Bright Minds Biosciences Announces Positive Findings from its DBA/2 Mouse Model Study Evaluating BMB-101

Bright Minds Biosciences Announces Positive Findings from its DBA/2 Mouse Model Study Evaluating BMB-101

- BMB-101 demonstrated a complete elimination of drop attacks in the DBA/2 mouse model - - The DBA/2 model is highly predictive of sudden unexpected death in epilepsy (SUDEP) - - Findings highlight BMB-101’s potential to address critical gaps in SUDEP …

Cycurion Secures $33 Million Contract Renewal to Enhance Cybersecurity for State-Level Public Higher Education Institutions

Cycurion Secures $33 Million Contract Renewal to Enhance Cybersecurity for State-Level Public Higher Education Institutions

MCLEAN, Va., May 13, 2025 (GLOBE NEWSWIRE) -- Cycurion (Nasdaq: CYCU) (“Cycurion” or the “Company”), a trusted leader in IT cybersecurity solutions and AI, announces that it has been awarded a significant contract renewal by a major state-level public …

Affimed Announces Filing for the Opening of Insolvency Proceedings

Affimed Announces Filing for the Opening of Insolvency Proceedings

MANNHEIM, Germany, May 13, 2025 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced its decision to file an application for …

Atsign's NoPorts Solution Creates First "Invisible Cloud" on Amazon Web Services (AWS)

Atsign's NoPorts Solution Creates First "Invisible Cloud" on Amazon Web Services (AWS)

SAN JOSE, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Atsign today announced the successful deployment of an "invisible cloud" environment on Amazon Web Services (AWS), leveraging its innovative NoPorts technology. This breakthrough delivers a new level of …

XRP News: Vaultro Finance Presale Moves Fast — Early Investors Eye Massive 30% Listing Gain on XRP’s Hottest DeFi Protocol

XRP News: Vaultro Finance Presale Moves Fast — Early Investors Eye Massive 30% Listing Gain on XRP’s Hottest DeFi Protocol

SINGAPORE, May 13, 2025 (GLOBE NEWSWIRE) -- With XRP breaking past $2.50 and reclaiming its position as one of the top three cryptocurrencies by market cap, investor enthusiasm is flooding into the XRP Ledger ecosystem, and one project is stealing the …

Delinea Begins FedRAMP High Authorization Process for Secret Server

Delinea Begins FedRAMP High Authorization Process for Secret Server

SAN FRANCISCO, May 13, 2025 (GLOBE NEWSWIRE) -- Delinea, a pioneering provider of solutions for securing human and machine identities through centralized authorization, has initiated the FedRAMP High authorization process for Secret Server, an industry- …

SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury

SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury

DENVER, May 13, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced …

Candel Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Candel Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Announced accepted oral presentation of positive phase 3 randomized placebo controlled clinical trial results of CAN-2409 (aglatimagene besadenovec) in localized prostate cancer at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting …

Plotly Honored as Bronze Stevie Award Winner In 2025 American Business Awards

Plotly Honored as Bronze Stevie Award Winner In 2025 American Business Awards

MONTREAL, May 13, 2025 (GLOBE NEWSWIRE) -- Plotly, the premier Data App platform for Python, has been named a Bronze Stevie® Award winner in the Artificial Intelligence/ Machine Learning Solution – Other category in The 23rd Annual American Business Awards …

Werewolf Therapeutics to Participate in Hanson Wade’s 6th Annual Cytokine-Based Drug Development Summit

Werewolf Therapeutics to Participate in Hanson Wade’s 6th Annual Cytokine-Based Drug Development Summit

WATERTOWN, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate …

Design Therapeutics to Participate in 2025 RBC Capital Markets Healthcare Conference

Design Therapeutics to Participate in 2025 RBC Capital Markets Healthcare Conference

CARLSBAD, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in a …

Artelo Biosciences Provides Business Update and Reports First Quarter 2025 Financial Results

Artelo Biosciences Provides Business Update and Reports First Quarter 2025 Financial Results

SOLANA BEACH, Caif., May 13, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic, …

Avadel Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference

Avadel Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference

DUBLIN, May 13, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the H.C. …

Advanced Technology International Acquires Carrot

Advanced Technology International Acquires Carrot

SUMMERVILLE, S.C., May 13, 2025 (GLOBE NEWSWIRE) -- We are excited to announce that effective March 31, 2025, Advanced Technology International (ATI), a South Carolina based 501(c)3 public service nonprofit, acquired the assets of The Common Pool, LLC, dba …

red violet to Present at the 25th Annual B. Riley Securities Investor Conference

red violet to Present at the 25th Annual B. Riley Securities Investor Conference

BOCA RATON, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- Red Violet, Inc. (NASDAQ: RDVT), a leading analytics and information solutions provider, today announced that it will present at the 25th Annual B. Riley Securities Investor Conference being held May 21-22 …

Monopar Therapeutics Reports First Quarter 2025 Financial Results and Recent Developments

Monopar Therapeutics Reports First Quarter 2025 Financial Results and Recent Developments

WILMETTE, Illinois, May 13, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, today …

CareCloud Named “Top Healthcare IT Pick for 2025” by Maxim Group; AI Initiative Recognized as Key Growth Driver

CareCloud Named “Top Healthcare IT Pick for 2025” by Maxim Group; AI Initiative Recognized as Key Growth Driver

SOMERSET, N.J., May 13, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare technology and generative AI solutions, today announced that Maxim Group, LLC (“Maxim Group”), a leading …

Mindera Health™ announces publication of randomized, prospective clinical utility study demonstrating improved psoriasis patient outcomes

Mindera Health™ announces publication of randomized, prospective clinical utility study demonstrating improved psoriasis patient outcomes

Vista, CA, May 13, 2025 (GLOBE NEWSWIRE) -- Mindera Health, a leader in precision medicine for dermatological conditions, today announced positive results from the completion of a randomized, prospective clinical trial (MATCH) aimed at demonstrating the …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service